Sanofi SA

Sanofi's Destiny 6 energy — caretaker, healer and protector — is expressed through a portfolio that emphasises vaccines, rare diseases and immunology — the medical fields where patient dependency is highest and the human cost of failure most visible. The company's Vaccines Global Business Unit, which supplies over 500 million doses annually, is a 6 organisation doing what 6s do: accepting the responsibility of caring for the most vulnerable. The Dupixent blockbuster — now treating millions with eczema, asthma and COPD — embodies the 6's vision of relieving chronic suffering at scale.

Investor alignment: Best aligned with Life Path 6 healthcare investors and Life Path 9 humanitarian shareholders who prioritise portfolio companies with genuine patient impact.